Industry expertise

Pharmaceuticals market research in India

Prescriber, chemist and patient research for Indian and global pharma companies.

Quick answer

Market Research India is a specialist pharmaceuticals research consultancy in India. We interview physicians, kols, chemists in Tamil, Telugu, Kannada, Malayalam, Marathi, Gujarati, Hindi, Punjabi and English, with field teams in 50 cities and 4 methods matched to how this sector actually buys.

Proposal in 24 hours
Scoped, itemised and fixed-fee.
50 cities, 14 languages
Our own supervised field teams.
Senior-led, NDA-first
A research director on every project.

2,400+

Projects delivered

Cities with field teams

Industries covered

Indian languages

The decisions we help you make

An Indian pharma brand is built in two conversations: the one a medical representative has with a prescriber, and the one a patient has with the chemist who may substitute at the counter. Measuring only the first explains why scripts were written, never why they were not filled.

How do doctors pick between brands?
What is the trade margin structure?
Which therapy areas are growing fastest?
Which prescriber segment deserves more field-force coverage, and which can move to digital detailing?
Does the trade margin structure support the launch price, or will substitution eat the script?

Tell us which of these you are actually facing and the design follows — sample, method and analysis plan are all downstream of the decision.

Who we talk to, and how we reach them

Most research disappoints at recruitment, not at analysis. These three audiences each need their own frame, their own screener and their own incentive logic.

Physicians
Drawn from our verified panel by specialty and patient load, with NMC registration confirmed, quotas on city class and practice setting, and no respondent interviewed more than once a quarter.
KOLs
Identified by publication record, trial participation and society office held, approached by name, and interviewed by a researcher briefed on the therapy area so the hour is worth their time.
Chemists
Sampled from outlet lists around the target prescriber catchments, screened on monthly therapy-area throughput, with stock checks verifying what is actually dispensed and what is substituted.

Interviews run in Tamil, Telugu, Kannada, Malayalam, Marathi, Gujarati, Hindi, Punjabi and English, with every questionnaire translated and back-translated before fieldwork. Moderators and interviewers are briefed on the pharmaceuticals category itself, not handed a script — which is the difference between a respondent answering politely and a respondent explaining themselves.

Methods that fit this sector

Method should follow the market, not the other way round. These are the approaches that fit how this sector actually behaves.

What a typical study looks like

This is what a mid-sized study in this sector usually looks like. Smaller qualitative reads and larger tracking programmes scale from here.

Indicative scope — pharmaceuticals study

Typical sample: n=300 prescribers across 4 specialties and 8 cities, 12 KOL depths and a 150-chemist counter check
Who we interview: Physicians, KOLs, Chemists — each recruited against a separate screener rather than drawn from one general sample.
Core methods: Healthcare Market Research, In-Depth Interviews, Competitor Analysis, Quantitative Surveys
Fieldwork window: 5–6 weeks, with KOL interviews scheduled first
Standard deliverables: Prescriber insights, Patient journey maps, Launch readiness, Transcripts
Signature output: A prescriber segmentation with the detailing implications costed segment by segment
Lead time: 8–10 weeks from sign-off to debrief

Compliance, ethics and data quality

Research in this sector carries obligations that a generic fieldwork house will not have thought about. These are the ones we build into the protocol before the first interview is scheduled.

Pharmacovigilance built in
Every interviewer is trained to recognise adverse events, and any AE or product-quality complaint reaches your PV team within 24 hours with consent to re-contact.
Fair-market-value honoraria
Physician and KOL payments are benchmarked, documented and disclosable, so the engagement survives a UCPMP or transparency review.
No promotion by proxy
A research interview is not a detailing call. Stimulus is neutral, unbranded where the design requires it, and no claim is made for a product during fieldwork.
Verification you can audit
Every physician and chemist we count is screened against a written definition, de-duplicated, GPS- and timestamp-logged in the field, and re-contacted on a 10% back-check with 10% of audio audited by a supervisor who did not run the interview.

What we will not do on a pharmaceuticals study

We will not substitute an audience without telling you, quietly loosen a screener to hit a quota, interview anyone who has not understood what they are consenting to, or move identifiable personal data outside India without your written agreement. If the fieldwork cannot be done properly, we say so at proposal stage rather than at debrief.

How we work

Our research process

01
Discovery
We turn your business question into clear research objectives.
02
Design
Sampling, method, questionnaire and discussion guides, translated into local languages.
03
Fieldwork
Supervised field teams with GPS, audio and back-check quality control.
04
Analysis
Statistical and thematic analysis by senior researchers.
05
Insight
Board-ready reports, dashboards and workshops with clear recommendations.

Where the sector concentrates

The Indian cities that matter most for pharmaceuticals

Pharmaceuticals is concentrated rather than spread: 5 cities carry most of the sector's weight, so we start there and add the metros that supply the rest of the demand. Each page covers pharmaceuticals research in that city specifically.

Before you brief us

Frequently asked questions

What does a pharmaceuticals research project cost in India?

Cost follows the sample, the seniority of the audience and the number of cities. Reaching physicians costs a fraction of what it costs to reach chemists, so the audience mix moves the number far more than the headline interview count. Send a brief and you get a fixed-fee proposal within 24 hours.

Which cities should a pharmaceuticals study cover?

Start where the sector concentrates — Hyderabad, Ahmedabad, Aurangabad, Visakhapatnam, Goa — then add markets that match your distribution rather than the national map. Most clients run four to eight cities so results can be compared side by side.

How do you make sure respondents are genuinely kols?

Each audience has its own written screener and its own frame. Respondents are de-duplicated against past projects, fieldwork is GPS- and timestamp-logged, 10% are re-contacted on a back-check and 10% of audio is audited by a supervisor who did not conduct the interview.

How long does a pharmaceuticals study take?

Fieldwork of the scope described above runs 5–6 weeks, with KOL interviews scheduled first, and the whole project is typically 8–10 weeks from sign-off to debrief. Fieldwork usually begins five to seven working days after sign-off, once screeners and translations are approved.

Which methods suit pharmaceuticals research best?

For this sector we most often use healthcare market research, in-depth interviews, competitor analysis, quantitative surveys. The right combination depends on whether you need to size something, explain it or test it — a brief that names the decision gets a sharper design than one that names a method.

What safeguards apply to pharmaceuticals fieldwork?

Every interviewer is trained to recognise adverse events, and any AE or product-quality complaint reaches your PV team within 24 hours with consent to re-contact. Alongside that, all personal data is collected on informed consent, held in India, pseudonymised before analysis and deleted on an agreed schedule, in line with the DPDP Act, 2023 and the ESOMAR code.

Sector at a glance

Hub cities: 5
Audiences covered: 3
Fieldwork window: 5–6 weeks
Lead time: 8–10 weeks
Proposal: Within 24 hours

See related case studies

Keep exploring

Pharmaceuticals research, city by city and method by method

Fifty cities, twenty methods and the sectors that sit closest to pharmaceuticals. Each page is written for that specific combination of market and approach.

Tier 1 metros

Full-scale quantitative fieldwork, viewing-facility groups and senior pharmaceuticals interviews in the eight largest markets.

Tier 2 growth markets

Forty-two cities where pharmaceuticals demand is forming fastest, each covered by a supervised local field team.

Show 34 more

Sectors that sit next to this one

These most often appear in the same programme as a pharmaceuticals study, either as an adjacent market or a shared audience.

All other industries

The rest of the thirty sectors we hold dedicated field and analysis experience in.

Show 17 more

Next step

Make your next pharmaceuticals decision with evidence.